ECCO 2016: Professor David Rubin (Chicago, USA), Dr Charlie Lees (Edinburgh, UK) and Dr Peter Irving (London, UK) discuss when to cycle biologics within class and when to switch classes for patients failing on anti-TNF therapy.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
